A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

NCT07570316 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
230
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx